Precision BioSciences, Inc.DTILNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank77
5Y CAGR-7.8%
Year-over-Year Change
Year-over-year operating cash flow growth rate
5Y CAGR
-7.8%/yr
Long-term compound
Percentile
P77
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 26.33% |
| Q3 2025 | 24.67% |
| Q2 2025 | -6.40% |
| Q1 2025 | -1.98% |
| Q4 2024 | -216.02% |
| Q3 2024 | 60.24% |
| Q2 2024 | 21.66% |
| Q1 2024 | -125.35% |
| Q4 2023 | 63.53% |
| Q3 2023 | -9.27% |
| Q2 2023 | 32.83% |
| Q1 2023 | -44.05% |
| Q4 2022 | -174.84% |
| Q3 2022 | 220.48% |
| Q2 2022 | 16.10% |
| Q1 2022 | -21.92% |
| Q4 2021 | 0.94% |
| Q3 2021 | 23.72% |
| Q2 2021 | -146.04% |
| Q1 2021 | 606.04% |
| Q4 2020 | 39.47% |
| Q3 2020 | 13.87% |
| Q2 2020 | 0.42% |
| Q1 2020 | -26.05% |
| Q4 2019 | -47.07% |
| Q3 2019 | 15.67% |
| Q2 2019 | 16.74% |
| Q1 2019 | -54.17% |
| Q4 2018 | 14.19% |
| Q3 2018 | -61.62% |
| Q2 2018 | 35.59% |
| Q1 2018 | 0.00% |